Financials Shenzhen YHLO Biotech Co., Ltd.

Equities

688575

CNE100005204

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
24.29 ^CNY	+3.05%		+5.47%	+6.21%

May. 17	Certain A Shares of Shenzhen YHLO Biotech Co., Ltd. are subject to a Lock-Up Agreement Ending on 17-MAY-2024.	CI
Apr. 19	Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Valuation

Fiscal Period: December	2021	2022	2023	2024	2025	2026
Capitalization ¹	13,993	11,142	12,993	13,828	-	-
Enterprise Value (EV) ¹	13,993	11,142	12,993	13,828	13,828	13,828
P/E ratio	65.2 x	11 x	36.9 x	28.7 x	21.5 x	16.6 x
Yield	1.16%	-	-	-	-	-
Capitalization / Revenue	11.9 x	-	6.33 x	6.1 x	4.92 x	3.94 x
EV / Revenue	11.9 x	-	6.33 x	6.1 x	4.92 x	3.94 x
EV / EBITDA	-	-	23.9 x	18.7 x	14 x	11.7 x
EV / FCF	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-
Price to Book	9.17 x	-	5.08 x	4.69 x	3.89 x	3.28 x
Nbr of stocks (in thousands)	567,000	567,000	568,129	569,276	-	-
Reference price ²	24.68	19.65	22.87	24.29	24.29	24.29
Announcement Date	2/18/22	2/27/23	2/23/24	-	-	-

¹CNY in Million²CNY

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	-	1,178	-	2,053	2,268	2,811	3,509
EBITDA ¹	-	-	-	543.4	739.6	985.3	1,182
EBIT ¹	-	226.8	-	340.5	522.8	704.5	870.2
Operating Margin	-	19.26%	-	16.59%	23.05%	25.06%	24.8%
Earnings before Tax (EBT) ¹	-	227.8	-	330.1	518.1	699.4	864.3
Net income ¹	210.5	204.7	-	358.4	481.4	644.2	832.9
Net margin	-	17.38%	-	17.46%	21.23%	22.92%	23.74%
EPS ²	0.4143	0.3786	1.780	0.6200	0.8460	1.132	1.468
Free Cash Flow	-	-	-	-	-	-	-
FCF margin	-	-	-	-	-	-	-
FCF Conversion (EBITDA)	-	-	-	-	-	-	-
FCF Conversion (Net income)	-	-	-	-	-	-	-
Dividend per Share ²	-	0.2857	-	-	-	-	-
Announcement Date	4/22/21	2/18/22	2/27/23	2/23/24	-	-	-

¹CNY in Million²CNY

Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December	2024 Q1
Net sales ¹	431.3
EBITDA	-
EBIT	-
Operating Margin	-
Earnings before Tax (EBT)	-
Net income ¹	66.03
Net margin	15.31%
EPS	-
Dividend per Share	-
Announcement Date	4/19/24

¹CNY in Million

Estimates

Balance Sheet Analysis

Fiscal Period: December	2020	2021	2023	2024	2025	2026
Net Debt	-	-	-	-	-	-
Net Cash position	-	-	-	-	-	-
Leverage (Debt/EBITDA)	-	-	-	-	-	-
Free Cash Flow	-	-	-	-	-	-
ROE (net income / shareholders' equity)	-	17.2%	14.3%	15.7%	17.8%	19.3%
ROA (Net income/ Total Assets)	-	-	9.46%	11.6%	13.7%	14.8%
Assets ¹	-	-	3,789	4,150	4,702	5,628
Book Value Per Share ²	-	2.690	4.510	5.180	6.240	7.400
Cash Flow per Share ²	-	0.4600	-0.1300	1.200	1.220	1.520
Capex ¹	-	373	663	412	373	482
Capex / Sales	-	31.64%	32.28%	18.15%	13.28%	13.73%
Announcement Date	4/22/21	2/18/22	2/23/24	-	-	-

¹CNY in Million²CNY

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Shenzhen YHLO Biotech Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

24.29 CNY

Average target price

30.22 CNY

Spread / Average Target

+24.42%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Medical Equipment

	1st Jan change	Capi.
SHENZHEN YHLO BIOTECH CO., LTD.	+6.21%	1.91B
SHOCKWAVE MEDICAL, INC.	+75.69%	12.57B
PENUMBRA, INC.	-24.68%	7.34B
MASIMO CORPORATION	+6.22%	6.61B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+12.58%	5.39B
GETINGE AB	-16.63%	4.84B
APT MEDICAL INC.	+26.90%	4.53B
ASAHI INTECC CO., LTD.	-21.14%	3.91B
INARI MEDICAL, INC.	-22.99%	2.91B
NOVOCURE LIMITED	+47.42%	2.37B

Medical Equipment